China's Ministry Of Industry And Information Technology Gives Sinovac Biotech Co., Ltd Additional 3 Million Dose Purchasing Order Of H1N1 Vaccine
This article was originally published in PharmAsia News
Executive SummarySinovac Biotech received an additional purchasing order from China's Ministry of Industry and Information Technology Sep. 29 to manufacture its H1N1 vaccine for 3 million people
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.